Table 1.
Baseline characteristics of those patients who were alive at final follow-up and those who were deceased.
| Patient characteristic | Alive (n = 67) | Deceased (n = 88); |
|---|---|---|
| Male, n (%) | 43(64.2%) | 47(53.4%) |
| Mean age (SD) | 60.8(12.5) | 71.1(13.5) |
| Mean largest basal diameter, mm (SD) | 13.1(3.71) | 15.7(4.88) |
| Missing, n (%) | 0(0%) | 3(3.41%) |
| Mean tumour thickness, mm (SD) | 9.3(3.2) | 9.9(3.6) |
| Missing, n (%) | 0(0%) | 3(3.41%) |
| AJCC stages, n (%) | ||
| I | 1(1.5%) | 0(0%) |
| IIA | 12(17.9%) | 11(12.5%) |
| IIB | 26(38.8%) | 19(21.6%) |
| IIIA | 20(29.9%) | 35(39.8%) |
| IIIB | 6(9.0%) | 17(19.32%) |
| IIIC | 1(1.5%) | 0(0%) |
| IV | 1(1.5%) | 6(6.8%) |
| Missing | 0% | 0% |
| Monosomy 3, n (%) | ||
| Absent | 34 (50.75%) | 21 (23.86%) |
| Present | 17 (25.37%) | 39 (44.32%) |
| Missing | 16 (23.88%) | 28 (31.82%) |
| Chromosome 8 gain, n (%) | ||
| Absent | 27(40.3%) | 12(13.6%) |
| Present | 25(37.3%) | 51(58.0%) |
| Missing | 15(22.4%) | 25(28.4%) |
| Extraocular extension | ||
| Absent | 55 (82.1%) | 70 (79.5%) |
| Present | 12(17.9%) | 18 (20.4%) |
| Ciliary body | ||
| Absent | 38 (56.7%) | 40 (45.5%) |
| Present | 29 (43.3%) | 48 (54.5%) |
| Epithelioid cells | ||
| Absent | 44 (65.7%) | 57(64.8%) |
| Present | 23 (34.3%) | 31(35.2%) |
| Loops | ||
| Absent | 34 (50.7%) | 38(43.2%) |
| Present | 24 (35.8%) | 43(48.9%) |
| Missing | 9 (13.4%) | 7(8.0%) |
| Mean Mitosis rate (SD) | 2.9(2.3) | 3.9(3.2) |
| Missing n (%) | 3(0.04) | 3(0.03) |
| Follow-up time | ||
| Mean (SD) median | 6.8(0.8) | 3(1.9) |
| (IQR) (years) | 6.7(1.4) | 2.8(2.9) |
Patients deceased from all causes, including unknown, are included in this table.